Non-pharmacological therapies, such as physical activity interventions, are an appealing
alternative or add-on to current pharmacological treatment of cognitive symptoms in patients …

Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

A major unanswered question in the dementia field is whether cognitively unimpaired
individuals who harbor both Alzheimer’s disease neuropathological hallmarks (that is, amyloid-β …

Importance Amyloid-β positron emission tomography (PET) imaging allows in vivo detection
of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its …

A ‘frontal variant of Alzheimer’s disease’ has been described in patients with predominant
behavioural or dysexecutive deficits caused by Alzheimer’s disease pathology. The …

Neuroinflammation is thought to play a pivotal role in many diseases affecting the brain,
including Alzheimer's disease, multiple sclerosis and stroke. Neuroinflammation is characterised …

The influence of cannabis on mental health receives growing scientific and political attention.
An increasing demand for treatment of cannabis dependence has refueled the discussion …

Regional functional connectivity (FC) of 39 patients with Alzheimer's disease (AD), 23 patients
with mild cognitive impairment (MCI), and 43 healthy elderly controls was studied using …

Since its opening in 2000, patient care and research go hand in hand at the Alzheimer
center of the VU University Medical Center, both organized in such a way that they mutually …

Three sets of research criteria are available for diagnosis of Alzheimer’s disease in subjects
with mild cognitive impairment: the International Working Group-1, International Working …